Workflow
Adient(ADNT) - 2026 Q1 - Quarterly Results
2026-02-04 19:50
Exhibit 99.1 ADIENT PRESS RELEASE Feb. 4, 2026 Adient continues to execute its resilient operating model, driving Improved business performance, which helped offset headwinds associated with temporary customer production disruptions. For the quarter, Adlent's Adj .- BITDA totaled $207M, up $11M compared to Q1FY25, and Improved Its AdJ .- EBITDA margin by 10 bps over the same period last year to 5.7 %. We continued to win new and conquest business across all regions and significantly outpace the China market ...
Kennametal(KMT) - 2026 Q2 - Quarterly Results
2026-02-04 19:47
FOR IMMEDIATE RELEASE: DATE: February 4, 2026 Investor Relations Media Relations CONTACT: Michael Pici CONTACT: Lori Lecker PHONE: 412-790-0792 PHONE: 412-248-8224 michael.pici@kennametal.com lori.lecker@kennametal.com Exhibit 99.1 Kennametal Announces Fiscal 2026 Second Quarter Results PITTSBURGH, (February 4, 2026) – Kennametal Inc. (NYSE: KMT) (the "Company") today reported results for its fiscal 2026 second quarter ended December 31, 2025. "We are pleased with our second quarter results, which exceeded ...
Avery Dennison(AVY) - 2025 Q4 - Annual Results
2026-02-04 19:45
Exhibit 99.1 For Immediate Release AVERY DENNISON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS Delivered a solid year in a dynamic environment, reflecting the durability of our franchise MENTOR, Ohio, February 4, 2026 – Avery Dennison Corporation (NYSE:AVY) today announced preliminary, unaudited results for its fourth quarter and full year ended December 31, 2025. Non-GAAP financial measures referenced in this release are reconciled from GAAP in the attached financial schedules. Unless otherwise indi ...
Novartis(NVS) - 2025 Q4 - Annual Report
2026-02-04 19:45
As filed with the Securities and Exchange Commission on February 4, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSU ...
Evercore(EVR) - 2025 Q4 - Annual Results
2026-02-04 19:45
Exhibit 99.1 E V E R C O R E EVERCORE REPORTS RECORD FOURTH QUARTER AND FULL YEAR 2025 REVENUES; QUARTERLY DIVIDEND OF $0.84 PER SHARE | | Fourth Quarter Results | | | | | | | | | | | Full Year Results | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | U.S. GAAP | | | | Adjusted | | | | U.S. GAAP | | | | Adjusted | | | | | | Q4 2025 Q4 2024 | | | | Q4 2025 | | | Q4 2024 | 2025 | | | 2024 | 2025 | | | 2024 | | Net Revenues ($ mm) | $ 1,288.3 ...
Boston Scientific(BSX) - 2025 Q4 - Annual Results
2026-02-04 19:33
FOR IMMEDIATE RELEASE Boston Scientific announces results for fourth quarter and full year 2025 Marlborough, Mass. (February 4, 2026) -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported basis, 14.3 percent on an operational basis and 12.7 percent on an organic basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $672 milli ...
Equifax(EFX) - 2025 Q4 - Annual Results
2026-02-04 19:32
Exhibit 99.1 1550 Peachtree Street, N.W. Atlanta, Georgia 30309 NEWS RELEASE ATLANTA, FEBRUARY 4, 2026 -- Equifax (NYSE: EFX) today announced financial results for the quarter and full year ended December 31, 2025. ® "Equifax delivered strong fourth quarter revenue of $1.551 billion, up 9% on both a reported and local currency basis, that was $30 million above the midpoint of our October guidance. This was led by strong 20% U.S. Mortgage revenue growth, strong Workforce Solutions Government revenue growth, ...
Cognizant(CTSH) - 2025 Q4 - Annual Results
2026-02-04 19:32
Exhibit 99.1 Cognizant Reports Fourth Quarter and Full-Year 2025 Results Exceeds fourth quarter revenue guidance and full year guidance across revenue, adjusted operating margin, and adjusted EPS TEANECK, N.J., February 4, 2026 - Cognizant (Nasdaq: CTSH), one of the world's leading professional services companies, today announced its fourth quarter and full-year 2025 financial results. "I am deeply grateful to our over 350,000 employees who helped make 2025 a defining year for Cognizant in which we put our ...
Cencora(COR) - 2026 Q1 - Quarterly Results
2026-02-04 19:31
Exhibit 99.1 CENCORA REPORTS FISCAL 2026 FIRST QUARTER RESULTS Revenue of $85.9 billion for the First Quarter, a 5.5% Increase Year-Over-Year First Quarter GAAP Diluted EPS of $2.87 and Adjusted Diluted EPS of $4.08 Adjusted Operating Income Guidance Raised to Growth of 11.5% to 13.5% Adjusted Diluted EPS Guidance Range Reaf irmed at $17.45 to $17.75 for Fiscal 2026 Company Completes Acquisition of OneOncology CONSHOHOCKEN, PA, February 4, 2026 - Cencora, Inc. (NYSE: COR) reported that in its fiscal year 20 ...
Bio-Techne(TECH) - 2026 Q2 - Quarterly Results
2026-02-04 19:30
Exhibit 99.1 Bio-Techne Releases Second Quarter Fiscal 2026 Results Minneapolis/February 4, 2026/ Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ending December 31, 2025. Second Quarter FY2026 Highlights "I am pleased with the Bio-Techne team's continued execution in a stabilizing operating environment," said Kim Kelderman, President and Chief Executive Officer of Bio-Techne. "For the fourth consecutive quarter we delivered double-digit growth in our bigges ...